Andreas Bernkop-Schnürch

Andreas Bernkop-Schnürch (born in Klagenfurt 6 December 1965) is an Austrian pharmaceutical technologist, scientist, pharmacist, entrepreneur, inventor and professor at the Institute of Pharmacy, University of Innsbruck. His research centers on the areas of pharmaceutical sciences, drug delivery, cosmetic science, bionanotechnology and polymer engineering. He is the inventor of various novel technologies such as thiomers and zeta potential changing nanocarriers.

Andreas Bernkop-Schnürch
Andreas Bernkop-Schnürch
Born (1965-12-06) 6 December 1965
Klagenfurt, Austria
NationalityAustrian
Alma materUniversity of Vienna
Known forthiomers, peptide drug delivery, multifunctional polymers, self-emulsifying drug delivery systems
AwardsEurand Award (2000), Phoenix Science Award for Pharmacy (2005), Houska Award (2007), Austrian Nano Award (2008), Ernst Brandl Award (2015)
Scientific career
FieldsPharmaceutical Sciences
InstitutionsUniversity of Innsbruck, Institute of Pharmacy

Biography

Andreas Bernkop-Schnürch descends from a long-established Austrian apothecary family.[1] He was educated in pharmacy at the Institute of Pharmacy (M.Sc.) and in microbiology and genetics at the Institute of Microbiology and Genetics (D.Sc.), University of Vienna, finishing his doctorate in 1994. From 1994-1999 he worked as postdoctoral fellow at the Institute of Pharmacy, University of Vienna. In 1999 he applied to qualify as a professor by receiving the "venia docendi" in pharmaceutical technology. In 2003 Andreas Bernkop-Schnürch was appointed to a chair in pharmaceutical technology at the University of Innsbruck. From 2006-2013 he served as dean of the Faculty of Chemistry and Pharmacy.[2] Since then he heads the Institute of Pharmacy.[3] In parallel he works at his pharmacy (Bärenapotheke) in Sankt Veit an der Glan. Andreas Bernkop-Schnürch and his wife, Astrid, have three children. His hobbies are golf, mountain biking, tennis and wind- and kitesurfing.

Research

Andreas Bernkop-Schnürch is a leading scientist of multifunctional polymers in the field of drug delivery and therapy. He invented and pioneered thiolated polymers – thiomers – as a new generation of bio- and mucoadhesive polymers. Various medicines based on thiomers have already successfully passed clinical trials[4][5] and a first product for treatment of dry eye syndrome will soon reach the global pharmaceutical market.[6] Andreas Bernkop-Schnürch also pioneered zeta potential changing nanocarriers and contributed substantial basic knowledge to the field of self-emulsifying drug delivery systems (SEDDS) for mucosal delivery of macromolecular drugs.

He is currently a member of the Scientific Committee[7] of the Innovative Medicines Initiative (IMI) of the European Union in Brusseles giving advice on scientific priorities to be included in the Strategic Research Agenda for Horizon 2020 and on the scientific advisory board of the Nicotine Science Center,[8] Denmark. Andreas Bernkop-Schnürch is the founder of Mucobiomer Biotechnologische Forschungs- und Entwicklungs GmbH (now part of the Croma-Pharma GmbH), Thiomatrix Forschungs- und Beratungs GmbH and Green River Polymers Forschungs und Entwicklungs GmbH.

Awards

Andreas Bernkop-Schnürch has been awarded more than 20 national and international awards. These include:

  • HERBA-Award 1996
  • Research-Award of the City of Vienna 1999[9]
  • Eurand-Award 2000[10]
  • Best of Biotech Award 2001[11]
  • MBPW Award 2002[12]
  • Best of Biotech Award 2003[13]
  • Adventure X Award 2004[14]
  • Most Cited Paper Awards 2004 [15][16]
  • Phoenix Science Award for Pharmacy 2005[17]
  • de:Houskapreis Award 2007
  • Eurand Award 2007[18]
  • Austrian Nano Award 2008[19]
  • Ernst Brandl Award 2015[20]
  • Most Cited Paper Award 2017 [21]
  • Gattefossé North America Award for Excellence in Research & Development with Lipid Excipients 2017[22]

Selected works

He is author of over 350 research articles and reviews as well as editor and (co-)author of several books.

  • Bernkop-Schnürch, Andreas (1996). Oral Delivery of Macromolecular Drugs: Barriers, Strategies and Future Trends. Springer. ISBN 978-1-4419-0200-9.
  • Reis, RL; Neves, NM; Mano, JF; Gomes, ME; Marques, AP; Azevedo, HS (2008). Natural-Based Polymers for Biomedical Applications. CRC Press. ISBN 9781845694814.
  • Jayakumer, R; Prabaharan, M; Muzzarelli, RAA (2011). Chitosan for Biomaterials I. Springer. ISBN 978-3-642-23114-8.
  • Dumitriu, S; Popa, V (2013). Polymeric Biomaterials: Structure and Function, Volume 1. CRC Press. ISBN 9781420094701.
  • Bonengel, S; Bernkop-Schnürch, A (2014). "Thiomers - From bench to market". J. Control. Rel. 195: 120–129. doi:10.1016/j.jconrel.2014.06.047.
  • Partenhauser, A; Bernkop-Schnürch, A (2016). "Mucoadhesive polymers in the treatment of dry X syndrome". Drug Discov Today. 21: 1051–1062. doi:10.1016/j.drudis.2016.02.013. PMID 26944445.
  • Bonengel, S; Prüfert, F; Jelkmann, M; Bernkop-Schnürch, A (2016). "Zeta potential changing phosphorylated nanocomplexes for pDNA delivery". Int. J. Pharm. 504: 117–124. doi:10.1016/j.ijpharm.2015.10.021.
  • Perera, G; Zipser, M; Bonengel, S; Salvenmoser, W; Bernkop-Schnürch, A (2015). "Development of phosphorylated nanoparticles as zeta potential inverting systems". Eur. J. Pharm. Biopharm. 97: 250–256. doi:10.1016/j.ejpb.2015.01.017.
  • Bonengel, S; Prüfert, F; Perera, G; Schauer, J; Bernkop-Schnürch, A (2015). "Polyethylene imine-6-phosphogluconic acid nanoparticles-a novel zeta potential changing system". Int. J. Pharm. 483: 19–25. doi:10.1016/j.ijpharm.2015.01.041.
  • Leonaviciute, G; Bernkop-Schnürch, A (2015). "Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery". Expert Opin. Drug Deliv. 12: 1703–1716. doi:10.1517/17425247.2015.1068287.

As of June 2018 his publications have been cited over 17,000 and his H-index is 67[23]

gollark: It would be interesting to see what ridiculous things people can manage with no ridiculous anti-doping regulations getting in the way.
gollark: You could do that with men's sports if you allow some subset performance-enhancing drugs in vast quantities, actually.
gollark: I see.
gollark: ... how?
gollark: Or maybe some the people concerned about this are just vaguely transphobic, who knows.

References
  1. "Archived copy". Archived from the original on 2016-07-29. Retrieved 2016-07-22.CS1 maint: archived copy as title (link)
  2. https://www.uibk.ac.at/ipoint/kopf_der_woche/358333.html
  3. https://www.uibk.ac.at/pharmazie/
  4. https://clinicaltrials.gov/ct2/results?term=chitosan-n-acetylcysteine&Search=Search
  5. https://clinicaltrials.gov/ct2/results?term=thiomer&Search=Search
  6. "Archived copy". Archived from the original on 2016-07-29. Retrieved 2016-07-15.CS1 maint: archived copy as title (link)
  7. "Scientific Committee of IMI". Archived from the original on 2017-07-11. Retrieved 2016-11-16.
  8. "Nicotine Science Center".
  9. "Förderungspreise der Stadt Wien, Preisträger Naturwissenschaft seit 1991". Archived from the original on 2016-07-29. Retrieved 2016-06-13.
  10. "REMISE DES PRIX EURAND 2000".
  11. "derStandard - Wettbewerb "Best of Biotech"".
  12. "Founders Forum 2002".
  13. "Beteiligung an "BOB - Best of Biotech" übertrifft alle Erwartungen".
  14. "Adventure X Rückblick".
  15. "Most Cited Paper Award 2004 JCR" (PDF).
  16. "Most Cited Paper Award 2004 EJPS" (PDF).
  17. "PHOENIX Pharmazie Wissenschaftspreis 2005 an Rollinger und Bernkop-Schnürch".
  18. "Press release Eurand: Eurand Award Honors Achievements in Oral Drug Delivery Research".
  19. "Auszeichnung für Spitzenleistung in Nanowissenschaften".
  20. "Pharmazeut mit Prof. Ernst-Brandl-Preis ausgezeichnet".
  21. "Most Cited Paper Award 2017 EJPB JCR" (PDF).
  22. "Gattefossé North America Announces Recipient of 2017 Award for Excellence".
  23. "Google Scholar: Andreas Bernkop-Schnürch". Google Scholar. Google.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.